Magnetic Nanoparticle Transferrin Nanostructure for Extracellular Vesicle Isolation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The isolation and concentration of extracellular vesicles are challenging due to their small size and low density, requiring complex and expensive methods involving antibodies and elaborate equipment.

Innovation Solution

A nanostructure comprising magnetic nanoparticles linked with a transferrin family protein, which binds to extracellular vesicles and pathogens, allowing for their isolation and concentration using a magnetic field and electrostatic attraction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methods using antibodies and ultracentrifuges are used to isolate extracellular vesicles, then isolation selectivity is improved, but device complexity and cost increase

Engineering Contradiction:
Improveisolation selectivityVSAvoidexperimental method complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent replaces the mechanical ultracentrifugation system with a magnetic field-based separation system. Magnetic nanoparticles functionalized with transferrin family proteins are used to bind extracellular vesicles, and a magnetic field is applied to separate the bound vesicles from the sample, eliminating the need for expensive ultracentrifuges while maintaining isolation effectiveness

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces magnetic nanoparticles functionalized with transferrin family proteins as an intermediary between the magnetic field and extracellular vesicles. These nanoparticles serve as mediators that bind to the vesicles through protein-receptor interactions and enable magnetic separation, replacing the need for direct antibody-based methods

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If conventional methods using expensive antibodies are used to isolate extracellular vesicles, then isolation accuracy is improved, but cost increases

Engineering Contradiction:
Improveisolation accuracyVSAvoidcost
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent uses magnetic nanoparticles functionalized with transferrin family proteins as a cost-effective alternative to expensive antibodies. The nanoparticles can be synthesized at lower cost and reused multiple times, providing a economical solution that maintains high isolation accuracy through specific protein-receptor binding

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the binding mechanism from antibody-antigen interaction to transferrin family protein-receptor interaction on extracellular vesicles. This parameter change in the binding approach maintains specificity and accuracy while significantly reducing the cost of reagents

Inventive Principle:
Principle #35Parameter changes

3Reliability

If conventional methods are used to isolate extracellular vesicles, then isolation specificity is improved, but ease of operation deteriorates

Engineering Contradiction:
Improveisolation specificityVSAvoidexperimental procedure simplicity
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent replaces complex mechanical ultracentrifugation procedures with simple magnetic field application. The magnetic nanoparticles bound to extracellular vesicles are easily separated by applying a magnet to the tube, making the procedure simple and intuitive while maintaining high specificity through the specific binding of transferrin family proteins to vesicle receptors

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables efficient, cost-effective, and simple isolation of extracellular vesicles and pathogens without the need for expensive antibodies or complex equipment, utilizing magnetic and electrostatic forces.

Implementation Method 1

the magnetic force from a magnetic field

Methodology Applied
Scientific EffectMagnetic force: Magnetism

Implementation Method 2

the attractive force between the positive charge of the structure and the negative surface charge of the extracellular vesicles

Methodology Applied
Scientific EffectElectrostatic attraction: Electrostatics

Data Source

PatentUS20230028744A1Nanostructure comprising magnetic nanoparticles and transferrin family protein, method for preparing the same, and method for isolating or concentrating extracellular vesicles or pathogen
Publication Date: 2023.01.26 UI (UNIVERSITY IND FOUNDATION) YONSEI UNIVERSITY
  • US20230028744A1 patent drawing
  • US20230028744A1 patent drawing
  • US20230028744A1 patent drawing

AI summary

A nanostructure for isolating or concentrating extracellular vesicles or a pathogen, includes a transferrin family protein linked on magnetic nanoparticles. The nanostructure includes a transferrin family protein, and thus has selectivity for a pathogen or extracellular vesicles capable of binding to the transferrin family protein, and the synthesized nanostructure is positively (+) charged. The nanostructure includes magnetic nanoparticles, a target material is easily and simply isolated from other materials by magnetism when a magnetic field is applied.